Abstract:Hashimoto's thyroiditis (HT) is an autoimmune disorder with unclear molecular mechanisms. While current diagnosis is well-established, understanding of the gut-thyroid axis in HT remains limited. This study aimed to uncover novel molecular signatures in HT by integrating gut metagenome and host transcriptome data (miRNA/mRNA), potentially elucidating disease pathogenesis and identifying new therapeutic targets. We recruited 31 early HT patients and 30 healthy controls in a two-stage study (discovery and validation). Blood and fecal samples underwent RNA and metagenomic sequencing, respectively. Integrative analysis included differential expression, weighted correlation network, correlation and random forest analyses. Regression models and ROC curve analysis were used to evaluate the significance of identified molecular signatures in HT. Integrative analysis revealed subtle changes in gut microbiota diversity and composition in early HT, increased abundance of Bacillota_A and Spirochaetota at the phylum level, and significant differences in 24 genera and 67 species. Ecological network analysis indicated an imbalance in the gut microbiota with reduced inhibitory interactions against pathogenic genera in HT. Functional analysis showed changes in infection- and immune-related pathways. Three characteristic species (Salaquimonas_sp002400845, Clostridium_AI_sp002297865, and Enterocloster_citroniae) were identified as most relevant to HT. Analysis of miRNA and mRNA expression profiles uncovered pathways related to immune response, inflammation, infection, metabolism, proliferation, and thyroid cancer in HT. Based on correlations with HT and interactions between them, six characteristic RNAs (hsa-miR-548aq-3p, hsa-miR-374a-5p, GADD45A, IRS2, SMAD6, WWTR1) were identified. Furthermore, our study uncovered significant gut microbiota-host transcriptome interactions in HT, revealing enrichment in metabolic, immune, and cancer-related pathways, particularly with strong associations among those 9 key molecular signatures. The validation stage confirmed improved HT classification accuracy by combining these signatures (AUC = 0.95, ACC = 0.85), suggesting their potential significance in understanding HT pathogenesis. Our study reveals novel molecular signatures linking gut microbiome and host transcriptome in HT, providing new insights into the disease pathogenesis. These findings not only enhance our understanding of the gut-thyroid axis but also suggest potential new directions for therapeutic interventions in HT.

Progress in Diagnosis and Treatment of Hashimoto's Thyroiditis

Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview

Approach to the Patient with Hot Nodules in Hypothyroidism with Hashimoto′s Thyroiditis: Diagnosis and Treatment

Thyroid Antibodies in Hashimoto’s Thyroiditis Patients Are Positively Associated with Inflammation and Multiple Symptoms

The Clinical Diagnosis and Surgical Treatment of Hashimoto's Thyroiditis

One Case of Hashimoto's Thyroiditis Complicated by Subacute Thyroiditis

Clinical analysis of 77 cases with primary hypothyroidism

Traditional Chinese Medicine for Hashimoto's Thyroiditis: Focus on Selenium and Antioxidant Phytochemicals

The Progress of Immunotherapy for Hashimoto′s Thyroiditis

Mapping the path towards novel treatment strategies: a bibliometric analysis of Hashimoto's thyroiditis research from 1990 to 2023

[Hard Nut to Crack in Diagnosis of Pituitary Hyperplasia Secondary to Primary Hypothyroidism and Reasons of Misdiagnosis].

Analysis of Diagnosis and Treatment of Hashimoto Thyroiditis and Subacute Thyroiditis

Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto's Thyroiditis and Its Treatment

Clinical efficacy and molecular mechanism of Chinese medicine in the treatment of autoimmune thyroiditis

Integrative Analysis of Gut Microbiome and Host Transcriptome Reveal Novel Molecular Signatures in Hashimoto's Thyroiditis.

Analysis of the Diagnosis and Treatment of 10 Cases of Chronic Adrenal Cortex Hypofunction

Progress in the Study of Pathogenesis, Diagnosis and Therapeutics in Thyroid Hormone Insensitivity Syndrome

Progress of diagnosis and treatment of thyrotropin-secreting pituitary adenomas

Autoimmune thyroid disease in patients of thyroid hormone insensitivity syndrome:5 cases report and literature re-view

Hypothyroidism in Context: Where We’ve Been and Where We’re Going

Clinical comparative efficacy and therapeutic strategies for the Hashimoto's thyroiditis: A systematic review and network meta-analysis